Education
About Us
Working with TipRanks
Follow Us
Recce Pharmaceuticals Ltd. (AU:RCE)
:RCE
RESEARCH TOOLSreports
See the Price Targets and Ratings of:
RCE Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
AU$0.5
Hold
38.89%
Upside
Upgraded
07/23/25
The overall stock score of Recce Pharmaceuticals Ltd. is primarily impacted by its challenging financial performance, characterized by high leverage and consistent losses. Technical analysis provides some positive momentum signals, but long-term trends remain bearish. The valuation is undermined by a negative P/E ratio, reflecting potential overvaluation concerns. Strategic improvements are essential for future growth and stability.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
AU$0.5
Hold
38.89%
Upside
Upgraded
07/23/25
The overall stock score of Recce Pharmaceuticals Ltd. is primarily impacted by its challenging financial performance, characterized by high leverage and consistent losses. Technical analysis provides some positive momentum signals, but long-term trends remain bearish. The valuation is undermined by a negative P/E ratio, reflecting potential overvaluation concerns. Strategic improvements are essential for future growth and stability.
RCE Analyst Recommendation Trends
Rating
May 25
Jun 25
Jul 25
Strong Buy
0
0
0
Buy
0
0
0
Hold
1
5
9
Sell
0
0
3
Strong Sell
0
0
0
total
1
5
12
Each month's total comprises the sum of three months' worth of ratings.
RCE Stock Forecast FAQ
What is AU:RCE’s average 12-month price target, according to analysts?
Based on analyst ratings, Recce Pharmaceuticals Ltd.’s 12-month average price target is 0.50.
What is AU:RCE’s upside potential, based on the analysts’ average price target?
Recce Pharmaceuticals Ltd. has 38.89% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Recce Pharmaceuticals Ltd. a Buy, Sell or Hold?
Recce Pharmaceuticals Ltd. has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Recce Pharmaceuticals Ltd.’s share price target?
The average share price target for Recce Pharmaceuticals Ltd. is 0.50. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is AU$0.50 ,and the lowest forecast is AU$0.50. The average share price target represents 38.89% Increase from the current price of AU$0.36.
The highest analyst share price target is AU$0.50 ,and the lowest forecast is AU$0.50. The average share price target represents 38.89% Increase from the current price of AU$0.36.
What do analysts say about Recce Pharmaceuticals Ltd.?
Recce Pharmaceuticals Ltd.’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of Recce Pharmaceuticals Ltd.?
To buy shares of AU:RCE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.